Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
TOI

TOI - The Oncology Institute, Inc. Stock Price, Fair Value and News

$3.01-0.05 (-1.63%)
Market Closed

70/100

TOI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

70/100

TOI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$4.53

Target 3M

$3.6

Target 6M

$3.88

TOI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TOI Price Action

Last 7 days

-10.7%

Last 30 days

-17.5%

Last 90 days

-34.4%

Trailing 12 Months

281.0%

TOI RSI Chart

TOI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TOI Valuation

Market Cap

296.1M

Price/Earnings (Trailing)

-4.47

Price/Sales (Trailing)

0.64

EV/EBITDA

-6.24

Price/Free Cashflow

-10.68

TOI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$4.53

Target 3M

$3.6

Target 6M

$3.88

TOI Fundamentals

TOI Revenue

Revenue (TTM)

461.0M

Rev. Growth (Yr)

36.7%

Rev. Growth (Qtr)

13.99%

TOI Earnings

Earnings (TTM)

-66.3M

Earnings Growth (Yr)

-2.43%

Earnings Growth (Qtr)

2.97%

TOI Profitability

EBT Margin

-14.40%

Return on Equity

540%

Return on Assets

-40.51%

Free Cashflow Yield

-9.36%

TOI Investor Care

Shares Dilution (1Y)

30.20%

Diluted EPS (TTM)

-0.64

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025403.2M424.4M461.0M0
2024342.7M361.1M378.9M393.4M
2023273.5M292.8M309.9M324.2M
2022209.6M220.7M233.4M252.5M
2021191.4M195.3M199.1M203.0M
2020000187.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About The Oncology Institute, Inc.

TOI
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
 WEBSITEtheoncologyinstitute.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES750

The Oncology Institute, Inc. Frequently Asked Questions

TOI is the stock ticker symbol of The Oncology Institute, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of The Oncology Institute, Inc. is 296.13 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check TOI's fair value in chart for subscribers.

The fair value guage provides a quick view whether TOI is over valued or under valued. Whether The Oncology Institute, Inc. is cheap or expensive depends on the assumptions which impact The Oncology Institute, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TOI.

As of Wed Jan 28 2026, TOI's PE ratio (Price to Earnings) is -4.47 and Price to Sales (PS) ratio is 0.64. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TOI PE ratio will change depending on the future growth rate expectations of investors.